Results 121 to 130 of about 48,863 (239)

Management of Tinea Capitis in children under 10 kg : Results from a French multicentre study

Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 2, Page e146-e150, February 2026.
A. Cornillault, S. Ranque, J. Bonigen, V. Heidelberger, M. Tardieu, A. Maruani, G. Desoubeaux, B. Bonniaud, C. Abasq‐Thomas, J. Pasteur, L. Poujade, C. Chiaverini, J. Miquel, C. Espagnon, A. Perrier, J. V. De Monleon, B. Sterling, J. Flament, A. S. Dussouil, L. Morin, S. Barbarot, A. Dadban, A. Morand, O. Chosidow, B. Guillot, L. Chouchana, R. Cohen, J.‐P. Gangneux, F. Botterel‐Chartier, S. Brun, J. Menotti, A. Folliat, M. A. Richard, S. Mallet, on behalf of Centre de Preuves en Dermatologie de la Société Française de Dermatologie, Groupe de recherche de la Société Française de Dermatologie Pédiatrique, Société Française de Mycologie Médicale, Société Française de Pédiatrie, Société de Pathologie infectieuse de langue française, Groupe Infectiologie Dermatologique et Infections Sexuellement Transmissibles   +39 more
wiley   +1 more source

Navigating Solute Carrier Transporters—A Comprehensive Review of Functionalized Small Molecule Probes for Target Identification and Characterization

Medicinal Research Reviews, Volume 46, Issue 1, Page 238-271, January 2026.
ABSTRACT Solute carrier transporters (SLCs) are integral membrane proteins that play pivotal roles in maintaining cellular homeostasis by mediating the transport of a diverse range of substrates across cell membranes. With their involvement in fundamental physiological processes such as nutrient uptake, neurotransmitter signaling, and drug transport ...
Majlen A. Dilweg, Tracie Widjaja, Adriaan P. IJzerman, Daan van der Es   +3 more
wiley   +1 more source

Characterizing Apixaban Pharmacokinetics Through Physiologically‐Based Pharmacokinetic Modeling: Critical Role of Biliary Secretion and Enterohepatic Circulation in Humans

CPT: Pharmacometrics &Systems Pharmacology, Volume 15, Issue 1, January 2026.
ABSTRACT Apixaban, a factor Xa inhibitor, is a direct oral anticoagulant with a well‐balanced elimination; it is eliminated evenly via feces, urine (with no active secretion), and as metabolites after oral administration. The common understanding is that biliary secretion and enterohepatic circulation (EHC) of apixaban are limited in humans, and that ...
Toshiaki Tsuchitani, Wen Kou, Masatoshi Tomi, Yuichi Sugiyama   +3 more
wiley   +1 more source

A prospective study comparing Itraconazole and systemic steroids as an adjunct to topical steroids in the post-operative management of Allergic fungal rhinosinusitis [PDF]

, 2022
Amala Salil, Nedha Joy, Bini Faizal
openalex   +1 more source

Mobile Cone‐Beam CT‐Guided Transbronchial Cryobiopsy of a Penicillium Granuloma via the Right Post‐Eparterial Bronchus

Respirology Case Reports, Volume 14, Issue 1, January 2026.
A post‐eparterial bronchus is a rare anatomical variant that can predispose to infection due to secretion stasis, especially in susceptible patients. Navigating this challenging airway can be achieved by the combination of an ultrathin bronchoscope for optimal access and mobile cone beam CT for definitive ‘tool‐in‐lesion’ confirmation.
Sze Shyang Kho, Chan Sin Chai, Cheng Lay Teh, Siew Teck Tie   +3 more
wiley   +1 more source

Imidazolium‐Based Ionic Liquids as Antifungal and Antibiofilm Agents Against Candida tropicalis

ChemistrySelect, Volume 11, Issue 4, 28 January 2026.
Candida sp. biofilms, particularly those formed on catheters, represent a major clinical challenge. This study evaluates ionic liquids using an experimental biofilm model, demonstrating significant antifungal activity and biofilm disruption, supporting their potential application as alternative strategies for device‐associated infection control ...
Giovanna de Jesus Agostinetto, Paula Reginatto, Lavínia da Veiga Pereira, Clarissa Piccinin Frizzo, Alexandre Meneghello Fuentefria   +4 more
wiley   +1 more source

MECHANISTIC STUDIES ON THE PHOTOTOXICITY OF ROSUVASTATIN, ITRACONAZOLE AND IMATINIB [PDF]

, 2014
Giacomo Nardi
openalex   +1 more source

Critical evaluation of real‐world evidence of repurposable medicines in the Alzheimer's disease drug development pipeline using a target trial emulation

Alzheimer's &Dementia: Translational Research &Clinical Interventions, Volume 12, Issue 1, January/March 2026.
Abstract INTRODUCTION Repurposing Food and Drug Administration (FDA)‐approved drugs could accelerate treatment development for Alzheimer's disease (AD). METHODS Using the MarketScan claims database (2011 to 2020), we applied a trial emulation approach in two base cohorts: (1) individuals with mild cognitive impairment (MCI cohort) and (2) individuals ...
Reina Tonegawa‐Kuji, Ehud Karavani, Michael Danziger, Pengyue Zhang, Yuan Hou, Yadi Zhou, Marina Bykova, Andrew A. Pieper, Michal Rosen‐Zvi, Jeffrey Cummings, Feixiong Cheng   +10 more
wiley   +1 more source

In vitro activities of terbinafine in combination with fluconazole and itraconazole against isolates of Candida albicans with reduced susceptibility to azoles [PDF]

, 1997
Francesco Barchiesi, Luigi Falconi Di Francesco, Giorgio Scalise   +2 more
openalex   +1 more source

The Inhibitory Effects of Zinc Oxide Nanoparticles on Clinical Isolates of Malassezia in Dogs

Veterinary Medicine and Science, Volume 12, Issue 1, January 2026.
Zinc oxide nanoparticles inhibit the growth and virulence of Malassezia pachydermatis clinical isolates from dogs. ZnO NPs exhibit potent fungicidal activity at low concentrations (MIC 3.90–7.81 ppm) and significantly downregulate the expression of Phospholipase A2 and Aspartyl proteinase genes, key virulence factors. This demonstrates the potential of
Alaleh Vazifehdust, Donya Nikaein, Matin Mozafari, Masoomeh Khanipour Machiani, Shahram Jamshidi, Javad Malakootikhah   +5 more
wiley   +1 more source